Literature DB >> 24021552

The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.

Paula L Hedley1, Jørgen K Kanters, Maja Dembic, Thomas Jespersen, Lasse Skibsbye, Frederik H Aidt, Ole Eschen, Claus Graff, Elijah R Behr, Sarah Schlamowitz, Valerie Corfield, William J McKenna, Michael Christiansen.   

Abstract

BACKGROUND: Mutations in CAV3, coding for caveolin-3, the major constituent scaffolding protein of cardiac caveolae, have been associated with skeletal muscle disease, cardiomyopathy, and most recently long-QT syndrome (LQTS) and sudden infant death syndrome. We examined the occurrence of CAV3 mutations in a large cohort of patients with LQTS. METHODS AND
RESULTS: Probands with LQTS (n=167) were screened for mutations in CAV3 using direct DNA sequencing. A single proband (0.6%) was found to be a heterozygous carrier of a previously described missense mutation, caveolin-3:p.T78M. The proband was also a heterozygous carrier of the trafficking-deficient Kv11.1:p.I400N mutation. The caveolin-3:p.T78M mutation was found isolated in 3 family members, none of whom had a prolonged QTc interval. Coimmunoprecipitations of caveolin-3 and the voltage-gated potassium channel subunit (Kv11.1) were performed, and the electrophysiological classification of the Kv11.1 mutant was carried out by patch-clamp technique in human embryonic kidney 293 cells. Furthermore, the T-wave morphology was assessed in mutation carriers, double mutation carriers, and nonmutation carriers by applying a morphology combination score. The morphology combination score was normal for isolated caveolin-3:p.T78M carriers and of LQT2 type in double heterozygotes.
CONCLUSIONS: Mutations in CAV3 are rare in LQTS. Furthermore, caveolin-3:p.T78M did not exhibit a LQTS phenotype. Because no association has ever been found between LQTS and isolated CAV3 mutations, we suggest that LQTS9 is considered a provisional entity.

Entities:  

Keywords:  arrhythmias, cardiac; genetics; ion channel; long–QT syndrome; molecular biology

Mesh:

Substances:

Year:  2013        PMID: 24021552     DOI: 10.1161/CIRCGENETICS.113.000137

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  8 in total

1.  Phloretin Alleviates Arsenic Trioxide-Induced Apoptosis of H9c2 Cardiomyoblasts via Downregulation in Ca2+/Calcineurin/NFATc Pathway and Inflammatory Cytokine Release.

Authors:  Vineetha Vadavanath Prabhakaran; Raghu Kozhiparambil Gopalan
Journal:  Cardiovasc Toxicol       Date:  2021-05-26       Impact factor: 3.231

Review 2.  Ion Channel Disorders and Sudden Cardiac Death.

Authors:  Anna Garcia-Elias; Begoña Benito
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

3.  MicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndrome.

Authors:  Paula L Hedley; Anting L Carlsen; Kasper M Christiansen; Jørgen K Kanters; Elijah R Behr; Valerie A Corfield; Michael Christiansen
Journal:  Scand J Clin Lab Invest       Date:  2014-05-08       Impact factor: 1.713

4.  Identification and functional analysis of a new putative caveolin-3 variant found in a patient with sudden unexplained death.

Authors:  Vincenzo Lariccia; Annamaria Assunta Nasti; Federica Alessandrini; Mauro Pesaresi; Santo Gratteri; Adriano Tagliabracci; Salvatore Amoroso
Journal:  J Biomed Sci       Date:  2014-06-10       Impact factor: 8.410

5.  Caveolin interaction governs Kv1.3 lipid raft targeting.

Authors:  Mireia Pérez-Verdaguer; Jesusa Capera; Ramón Martínez-Mármol; Marta Camps; Núria Comes; Michael M Tamkun; Antonio Felipe
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

6.  PTRF/Cavin-1 Deficiency Causes Cardiac Dysfunction Accompanied by Cardiomyocyte Hypertrophy and Cardiac Fibrosis.

Authors:  Takuya Taniguchi; Naoki Maruyama; Takehiro Ogata; Takeru Kasahara; Naohiko Nakanishi; Kotaro Miyagawa; Daisuke Naito; Tetsuro Hamaoka; Masahiro Nishi; Satoaki Matoba; Tomomi Ueyama
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

7.  Anesthesia for patients with PTRF mutations: a case report.

Authors:  Atsuko Hirano; Tomohiko Takada; Mariko Senda; Hidemasa Takahashi; Takeo Suzuki
Journal:  JA Clin Rep       Date:  2018-01-25

8.  The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability.

Authors:  Giulia Campostrini; Mattia Bonzanni; Alessio Lissoni; Claudia Bazzini; Raffaella Milanesi; Elena Vezzoli; Maura Francolini; Mirko Baruscotti; Annalisa Bucchi; Ilaria Rivolta; Matteo Fantini; Stefano Severi; Riccardo Cappato; Lia Crotti; Peter J Schwartz; Dario DiFrancesco; Andrea Barbuti
Journal:  Cardiovasc Res       Date:  2017-08-01       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.